Finance

Lists
KNE:CVE
Kane Biotech Inc
CA$0.030
0.00%
(0.00) 1D
Oct 1, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for KNE...
Open
CA$0.02
High
CA$0.03
Low
CA$0.02
Mkt. cap
6.16M
Avg. vol.
38.18K
Volume
5.13K
52-wk high
CA$0.04
52-wk low
CA$0.02
EPS
-CA$0.02
Beta
0.23
Shares outstanding
205.06M
Open
CA$0.02
High
CA$0.03
Low
CA$0.02
Mkt. cap
6.16M
Avg. vol.
38.18K
Volume
5.13K
52-wk high
CA$0.04
52-wk low
CA$0.02
EPS
-CA$0.02
Beta
0.23
Shares outstanding
205.06M
News stories
From web sources and news partners
About Kane Biotech Inc
CEO-
Employees-
Founded2001
HeadquartersWinnipeg, Manitoba, Canada
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.50K
-21.14K
43.22K
8.14K
Cost of goods sold
13.63K
-28.71K
47.12K
6.70K
Cost of revenue
13.63K
-28.71K
47.12K
6.70K
Research and development expenses
159.64K
114.94K
208.80K
114.09K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
378.67K
522.13K
460.61K
671.84K
Operating expense
538.31K
637.07K
669.40K
785.93K
Total operating expenses
551.93K
608.36K
716.52K
792.63K
Operating income
-543.43K
-629.50K
-673.30K
-784.48K
Other non operating income
-
-
-
-
EBT including unusual items
-607.34K
-654.86K
-710.60K
-829.78K
EBT excluding unusual items
-607.34K
-633.88K
-731.00K
-829.78K
Income tax expense
-
-108.00K
4.22K
3.86K
Effective tax rate
-
16.49%
-0.59%
-0.46%
Other operating expenses
-
-
-
-
Net income
-607.34K
-546.86K
-714.83K
-833.64K
Net profit margin
-7,146.08%
2,586.83%
-1,654.00%
-10,237.46%
Earnings per share
-
-
-
-
Interest and investment income
7.95K
1.81K
3.08K
3.38K
Interest expense
-71.86K
-10.14K
-57.88K
-47.00K
Net interest expenses
-63.91K
-8.33K
-54.80K
-43.61K
Depreciation and amortization charges
-
-
-
-
EBITDA
-445.94K
-614.14K
-654.30K
-771.44K
Gain or loss from assets sale
-
-27.01K
1.76K
-
AI content may include mistakes. Learn more
Google apps